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IL-10 knockout mice. These results suggest that infection 
with a virulent  T. cruzi strain alters NK cell-mediated regula-
tion of the adaptive immune response induced by DCs. This 
regulatory circuit where IL-10 appears to participate might 
lead to parasite persistence but can also limit the induction 
of a vigorous tissue-damaging T-cell response. 
 Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Natural killer (NK) and dendritic cells (DCs) are criti-
cal actors of the early immune response. NK cells, a 
unique lymphocyte population of the innate immune re-
sponse, play a central role in immune surveillance as a 
result of their cytokine production and cytolysis of in-
fected or tumor cells. DCs stand at the frontier of innate 
and adaptive immunity. Chemokines, cytokines and mi-
crobial components promote their maturation and mi-
gration into lymphoid tissues where they activate the an-
tigen-specific T-cell responses. The cooperative dialog 
between these cells during the innate immune response 
regulates the quality of the ongoing adaptive immune re-
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 Abstract 
 Early interactions between natural killer (NK) and dendritic 
cells (DC) shape the immune response at the frontier of in-
nate and adaptive immunity. Activated NK cells participate 
in maturation or deletion of DCs that remain immature. We 
previously demonstrated that infection with a high viru-
lence (HV) population of the protozoan parasite  Trypano-
soma cruzi downmodulates DC maturation and T-cell acti-
vation capacity. Here, we evaluated the role of NK cells in 
regulating the maturation level of DCs. Shortly after infec-
tion with HV  T. cruzi , DCs in poor maturation status begin to 
accumulate in mouse spleen. Although infection induces 
NK cell cytotoxicity and cytokine production, NK cells from 
mice infected with HV  T. cruzi exhibit reduced ability to lyse 
and fail to induce maturation of bone marrow-derived im-
mature DCs (iDCs). NK-mediated lysis of iDCs is restored by 
in vitro blockade of the IL-10 receptor during NK-DC inter-
action or when NK cells are obtained from  T. cruzi -infected 
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sponse against pathogens and tumors  [1, 2] . Once DCs 
mature, they release cytokines such as IL-12 or IL-15 with 
the capacity to induce NK cell activation and prolifera-
tion  [2] . Pathogen-primed NK cells secrete IFN-γ, TNF-α 
and GM-CSF, which can complete the process of DC 
maturation  [2] . NK cells can optimize the conditions for 
T-cell activation by eliminating autologous immature 
DCs (iDCs) that have failed to mature properly while 
sparing mature DCs  [1, 3–5] . This process adjusts the 
overall maturation level of the DC pool and appears to 
play a part in the balance towards immunogenic or regu-
latory responses  [1, 6, 7] .
 Chagas’ disease, caused by the protozoan parasite 
 Trypanosoma cruzi , affects over 10 million people in Lat-
in America  [8] . The onset of human pathology is ex-
tremely diverse, varying from a relatively benign asymp-
tomatic form to digestive compromise or a fatal cardiac 
course. Several lines of evidence indicate that the bio-
logical differences among  T. cruzi isolates delineate the 
host-parasite relationship and disease outcome  [9, 10] . 
The immune mechanisms triggered shortly after  T. cru-
zi infection seem to be essential for the control of early 
parasite duplication. In this sense, NK cells play a role in 
parasite control, mainly by their early IFN-γ production 
 [11–13] . However, NK are also able to kill extracellular 
parasites directly through contact-dependent mecha-
nisms  [14] . Humoral and cellular arms of the immune 
response are known to participate in the control of  T. 
cruzi infection but fail to achieve total pathogen clear-
ance. In addition, diverse studies show that  T. cruzi in-
fection elicits regulatory mechanisms able to curb im-
munity  [15, 16] . In this line of work, we demonstrated  in 
vivo and  in vitro that  T. cruzi and parasite-derived mol-
ecules can modulate DC maturation and function in a 
strain-dependent manner  [17–19] . Thus, it is relevant to 
understand the participation of NK cells in the matura-
tion or elimination of the iDCs in the context of  T. cruzi 
infection. Therefore, we used experimental murine in-
fection with two parasite populations displaying signifi-
cant biological differences: RA is a highly virulent (HV), 
fast-duplicating, pantropic strain belonging to the TcVI 
lineage isolated from an acutely infected child  [20] 
whereas K98 is a slow-duplicating, myotropic strain with 
low virulence (LV) belonging to TcI isolated from a 
chronically infected adult  [21–24] . Here, we show that 
iDCs subsets start to accumulate in the spleen very early 
upon infection with the HV strain but not with the LV 
strain. Even though NK cells from mice infected with 
both parasite populations become functionally activated 
in a similar extent, NK cells from mice infected with the 
HV strain exhibit impaired deletion of iDCs and do not 
support their maturation. The regulatory cytokine IL-10, 
which is produced during in vivo T. cruzi  infection,  ap-
pears to  participate in this regulatory mechanism involv-
ing NK cells and DCs.
 Methods 
 Mice 
 C3H/HeN and Balb/c male mice were supplied by the animal 
facilities at the IMPaM (Universidad de Buenos Aires, CONI-
CET) and IL-10 knock out (KO) male mice of Balb/c background 
by the animal facilities of the Fundación Instituto Leloir (Buenos 
Aires, Argentina). Mice were kept under standard conditions on 
a 12- hour light, 12-hour dark cycle in a temperature-controlled 
room (25 ± 2  °  C) with food and water ad libitum. All animal pro-
cedures were approved by institutional regulations of the Com-
mittee for the Care and Use of Laboratory Animals (approval No. 
RS2079/2007, Universidad de Buenos Aires) and in accordance 
with government regulations of the National Food Safety and 
Quality Service (SENASA, resolution No. RS617/2002, Argenti-
na). All efforts were made to minimize the number of animals 
used and their suffering.
 Parasites and Infection 
 Bloodstream forms (trypomastigotes) of the HV (RA) or the 
LV (K98)  T. cruzi populations were maintained by serial pas-
sages in CF1 mice. C3H/HeN mice were infected with 15,000 try-
pomastigotes of either  T. cruzi population inoculated into the 
hind footpad. Where indicated, IL-10KO male mice of Balb/c 
background and Balb/c controls were infected with the same in-
oculum by the same route. Sham-infected mice were inoculated 
with CF1 mouse blood. Parasitemia was monitored by counting 
the number of viable trypomastigotes in blood collected after ly-
sis with 0.87% ammonium chloride buffer. Mouse survival was 
recorded daily.
 Quantification of Tissue Parasite Burden by Quantitative PCR 
 In brief, tissue specimens were separately subjected to lysis in a 
buffer containing 50 m M Tris (pH 8; Promega, USA), 10 m M 
EDTA (Promega), 100 m M NaCl (Sigma, USA), 1% (w/v) SDS 
(Promega) and 300 μg/ml proteinase K (Promega). Samples were 
heated for 2 h at 55  °  C and DNA was purified by phenol extraction 
followed by ethanol precipitation. For PCR reaction, the  T. cruzi 
satellite nuclear repeat was amplified with primers SatFw 
(5 ′ -GCAGTCGGCKGATCGTTTTCG-3 ′ ) and SatRv (5 ′ - TTCAG
RGTTGTTTGGTGTCCAGTG-3 ′ ). The 20-μl reaction tube con-
tained 0.5 μ M of primers SatFw and SatRv, 3 m M MgCl 2 , 250 μ M 
of each dNTP, 0.5 U of platinum Taq polymerase (Invitrogen, Life 
Technologies, USA), SYBR Green (Invitrogen, Life Technologies) 
at a final concentration of 0.5× and 2 μl of sample DNA. Thermal 
cycling comprised an initial denaturation step for 5 min at 95   °   C, 
followed by 40 cycles at 94  °  C for 10 s, 65  °  C for 10 s and 72  °  C for 
10 s on an MJR-Opticon II device (Promega). Host cell number 
was assessed by quantifying the single copy murine-specific TNF-α 
gene in a separate PCR reaction, using primers TNF-5241 (5 ′ - TC
CCTCTCATCAGTTCTATGGCCCA-3 ′ ) and TNF-5411 (5 ′ - CA
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GCAAGCATCTATGCACTTAGACCCC- 3 ′ ) at a final concentra-
tion of 1 μ M . All other PCR reagents and cycling conditions were 
the same as for the T. cruzi satellite DNA amplification. The num-
ber of parasites was referred to that of the host cells. The standard 
curve for host cell determination was generated with DNA extract-
ed from serial 10-fold dilutions of previously quantified normal 
splenocyte cell suspensions. Standard curves for  T. cruzi were gen-
erated with DNA extracted from splenocyte cell suspensions con-
taminated with 10-fold dilutions of  T.cruzi epimastigotes. Epimas-
tigotes from Silvio X10 (TcI) and CL-Brener (TcVI)  T. cruz i strains 
were employed to standardize the amount of  T. cruzi satellite DNA 
for K98 (TcI) and RA (TcVI) strains, respectively  [25] .
 Cells 
 PBMC were isolated from blood samples by density gradient 
centrifugation using Histopaque-1083 (Sigma). Spleens were ex-
cised and homogenized with RPMI 1640 supplemented with 5% 
fetal bovine serum (FBS; Gibco-BRL, USA), 2-mercaptoethanol 
and antibiotics (penicillin 100 U/ml and streptomycin 100 μg/ml; 
Sigma). Erythrocytes were lysed and single cell suspensions were 
washed in RPMI 1640-10% FBS. Where needed, adherent mono-
nuclear cells were depleted by incubation for 1 h at 37   °   C. The vi-
ability of cells was consistently over >98%.
 Proliferation Assay 
 Excised spleens were homogenized and splenocytes (2.5 × 10 5 ) 
were cultured for 4 days at 37  °  C in RPMI 1640-10% FBS medium 
alone or with 5 μg/ml concanavalin A (Sigma) or 3 μg/ml anti-CD3 
(Pharmingen, USA) at a final volume of 200 μl by triplicate. Cul-
tures were pulsed with 1 μCi/well of [ 3 H]-thymidine (ICN, USA) 
during the last 24 h. Cells were harvested and analyzed in a Rack 
Beta liquid scintillation counter (Pharmacia, Sweden). Results 
were expressed as the mean count per minute (cpm) of culture ± 
SEM.
 Purification of NK Cells 
 DX5+ cells were isolated from nonadherent spleen cell frac-
tions by magnetic sorting using biotinylated anti-mouse CD49/
pan-NK cell (DX5) monoclonal antibodies bound to streptavi-
din-coated magnetic beads and miniMACS columns (Miltenyi 
Biotech GmbH, Germany) according to the manufacturer’s pro-
tocol. Cell populations were approximately 90% DX5+ cells by 
flow cytometry.
 iDC Generation 
 iDCs were obtained by culturing bone marrow cells supple-
mented with 30% supernatant from a granulocyte-macrophage 
colony-stimulating factor (GM-CSF)-expressing cell line (J558 
GM-CSF), as previously described  [26] .
 Flow Cytometry 
 The following antibodies were used: anti-CD49b (DX5), anti-
CD3 (145-2C11), anti-CD69 (H1.2F3), anti-CD11c (HL3), anti-
IEk (11-5.2), anti-IAd (39-10-8), anti-CD80 (16-10A1), anti-CD86 
(GL-1), anti-IFNγ (XGM.1) and anti-IL-10 (JES3–19F1) along 
with the appropriate isotype control antibodies (BD Biosciences or 
Caltag, UK). For intracellular cytokine staining, cells were incu-
bated with brefeldin A (10 μg/ml; Sigma) for the last 4 h of culture. 
After surface staining, the cells were fixed in 4% paraformaldehyde 
(20 min), permeabilized [0.1% saponin (Sigma) in PBS 10% FBS] 
and stained intracellularly. Samples were acquired on a FACSCal-
ibur (Becton Dickinson, USA), and data were analyzed with Cy-
flogic 1.2.1 free software (CyFlo Ltd, Finland).
 CD107a Assay 
 Nonadherent cell fractions were resuspended at 1 × 10 6 cells/
ml in RPMI 1640 supplemented with 10% FCS and incubated with 
FITC-conjugated anti-CD107a monoclonal antibody (BD Biosci-
ences) for 1 h. Then, protein transport inhibitors were added to 
prevent intracellular degradation of internalized CD107a-anti-
body complexes (monensin, 6 μg/ml; BD Biosciences) and exocy-
tosis (brefeldin A, 10 μg/ml). Cells were incubated for another 4 h 
at 37  °  C in 5% CO 2, washed with FACS buffer (PBS, 1% FCS, 1 m M 
EDTA, 0.05% sodium azide) and stained with the conjugated 
monoclonal antibodies anti-DX5 and anti-CD3.
 5-(6)-Carboxyfluorescein Succinimidyl Ester-Based in vitro 
Cytotoxicity Assay 
 NK cell cytotoxicity against YAC-1 and iDC cells was evalu-
ated in a 4-hour 5-(6)-carboxyfluorescein succinimidyl ester 
(CFSE)/propidium iodide (PI) flow-cytometric assay  [27] . Briefly, 
target cells were labeled with CSFE (5 μ M , Sigma) for 15 min at 
37   °   C in the dark. Then, they were cocultured at different ratios 
with purified NK effector cells from  T. cruzi -infected (18 h.p.i.) 
and control mice (5 × 10 4 target cells/well) in 96-well plates in a 
total volume of 200 μl RPMI 1640, 5% FCS/well. For in vitro 
blockade of IL-10R, 40 μg/ml of clone 1B1.3A or rat IgG isotype 
control (HPRN) from Santa Cruz Biotechnology (USA) were add-
ed at this step. After 4 h in a 5% CO 2 atmosphere at 37  °  C, PI was 
added (5 μ M ), and data were collected in a FACSCalibur (Becton 
Dickinson). Spontaneous (S) and maximum (M) cytotoxicity of 
target cells was determined in cultures with RPMI 1640-5% FCS 
and PBS-2% Tween-20 (Sigma), respectively. Percent NK cell ac-
tivity was calculated as: (PI incorporation by experimental sam-
ples – S)/(M – S) × 100.
 Statistics 
 Data were expressed as means ± SEM. The Mann-Whitney test 
and ANOVA followed by Bonferroni’s post hoc test were employ-
ed for comparisons between two and more groups. Differences in 
survival  between groups were analyzed by log-rank test. A value of 
p < 0.05 was considered significant. All tests were performed using 
the GraphPad prism version 5.00 for Windows (GraphPad, USA).
 Results 
 Differences in Outcome of Experimental Infection 
with Two T. cruzi Populations of Divergent Virulence 
 LV (K98  T. cruzi strain)-infected mice presented low 
and delayed parasitemia levels as well as low splenic par-
asite burden. No mortality was registered during the 
acute phase of infection in this group of mice ( fig. 1 a–c). 
HV (RA  T. cruzi strain)-infected mice exhibited elevated 
parasitemia levels; spleen parasite burden was 2–3 log 
units higher than with LV and only 50% of the mice 






ported  [28] , splenocytes from mice acutely infected 
(7 days post-infection, d.p.i.) with  T. cruzi  displayed poor 
mitogen-induced proliferation compared to uninfected 
mice. However, those from mice infected with the HV 
strain showed significantly lower values than with the LV 
strain ( fig. 1 d). Proliferation was restored in HV- and LV-
infected mice that reached the chronic phase of infection 
(90 d.p.i.; data not shown).
 iDC Subsets Accumulate in the Spleen during Acute 
Infection with the HV T. cruzi Population 
 Total cell number was significantly increased in the 
spleen of HV- and LV-infected animals 15 and 28 d.p.i., 
respectively ( fig. 2 a). Next, two distinct DC subsets re-
siding in the spleen were analyzed, a conventional 
CD11c high (CD11c hi ) DC subset and a CD11c  inter-
mediate (CD11c int ) semimature DC subset ( fig. 2 b). Fol-
lowing infection with the HV population, the frequency 
of the CD11c int DC subset started to increase (2 d.p.i.) 
and, later on, the absolute numbers of both CD11c hi and 
CD11c int DC subsets increased significantly in this gr-
oup of mice compared to the one infected with the LV 
population ( fig. 2 c, d). Infection with the HV strain dec-
reased significantly MHC class II expression at the surf-
ace of both CD11c hi and CD11c int DC subsets ( fig. 2 e, f). 
This phenomenon started early after infection (2 days) 



















































































 Fig. 1. Outcome of murine infection with the HV and LV  T. 
cruz i populations. C3H/HeN mice were infected with HV and 
LV strains. Parasitemia levels ( a ), parasite burden in the spleen 
measured by quantitative PCR ( b ) and survival ( c ) were regis-
tered at the indicated time points. Splenocytes from acutely in-
fected HV or LV  T. cruzi strains (7 d.p.i.) and control mice were 
cultured with concanavalin A (ConA; 5 μg/ml) or anti-CD3 
(3 μg/ml) or medium alone ( d ). Means ± SEM. One representa-
tive experiment of 2 using 6–10 individual mice per group is 
shown.  a ,  b Mann-Whitney test.  c log-rank (Mantel-Cox) test. 
 d ANOVA (Bonferroni’s post hoc test).  *  p < 0.05 and  * *  p < 0.01. 
T = Thymidine. 







































































































 Fig. 2. Accumulation of immature splenic DC subsets during acute 
in vivo HV  T. cruzi  infection.  a Total number of spleen cells in 
C3H/HeN mice infected with HV or LV T. cruzi  populations at the 
indicated time points.  b Dot plot representation of spleen cell sus-
pensions from a control mouse stained for CD11c and MHC class 
II (Ie-K) surface markers. The dotted line represents the limit be-
tween Ie-K-positive and -negative cells. CD11c hi and CD11c int 
splenic DC subsets are plotted in R1 and R2 regions, respectively. 
Frequency ( c ) and absolute cell number ( d ) of CD11c hi and CD-
11c int splenic DC subsets from infected mice. Surface expression 
of MHC II (Ie-K) by the splenic CD11c hi DC subset ( e ) and by the 
CD11c int DC ( f ) from infected mice. Means ± SEM ( a ,  c,  f ) of val-
ues obtained from 3 independent experiments with 3–5 pooled 
( e ,  f ) or independent ( a ,  c ,  d ) mice per group. Mann-Whitney test. 
 a ,  e ,  f  *  p < 0.05 HV vs. LV.  c ,  d  *  p < 0.05 HV CD11c int vs. LV 






 Early Infection with LV and HV T. cruzi Populations 
Increases Circulating NK Cell Frequency, Activation 
and Production of IFN-γ but Also of IL-10 Cytokines 
 Eighteen hours after infection with the HV  T. cruzi 
population, the relative number and activation (CD69 
expression) of circulating NK cells increased ( fig. 3 a). 
Circulating NK cells from mice infected with the LV 
population attained later (96 h.p.i.) the levels of those 
infected with the HV strain ( fig. 3 a). In the spleen, the 
relative number of NK cells was not modified during 
the first 96 h of  T. cruzi infection while their CD69 ex-
pression increased significantly upon infection with 
both parasite populations ( fig. 3 b). Regarding cytokine 
production by NK cells, 18 h after infection with the 
HV and LV  T. cruzi populations, there was an increase 
in the relative number of IFN-γ-positive NK cells 
(DX5+CD3–) from PBMC fractions and the spleen 
compared to sham-infected controls ( fig. 3 c, d). In ad-
dition, during early infection with both  T. cruzi popula-
tions, the number of NK cells producing IL-10 also in-
creased significantly at the same compartments ( fig. 3 c, 































































































































































































 Fig. 3. Frequency, activation and cytokine production by NK cells 
following  T. cruzi infection. C3H/HeN mice were infected with 
the HV and LV T. cruzi  populations and sham infected. PBMC 
(blood) and spleen cell suspensions (spleen) obtained at different 
time points after infection. Frequency of DX5+/CD3– cells and 
expression of CD69 by DX5+/CD3– cells were evaluated in 
PMBC ( a ) and spleen cell suspensions ( b ). Ex vivo intracellular 
production of IFN-γ and IL-10 by DX5+/CD3– cells from PBMC 
fractions ( c ) and spleen cell suspensions ( d ) 18 h.p.i. Dot plots 
show results from 1 representative experiment of 3 each using a 
pool of 3–5 mice per group. Histograms show results obtained 
from 3 independent experiments with 3–5 pooled mice per group 
(means ± SEM). ANOVA (Bonferroni’s post hoc test).  *  p < 0.05 
sham vs. LV and HV,  #  p < 0.05 sham vs. HV and LV.
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(online suppl. fig. 1; for all online suppl. material, see 
www.karger.com/doi/10.1159/000350242).
 NK Cells from Mice Infected with T. cruzi HV Strain 
Display Reduced Capacity to Eliminate Autologous 
iDCs 
 First, we measured the cytotoxic function of NK cells 
isolated from the spleen of  T. cruzi- and sham-infected 
mice using the NK-sensitive thymoma cell line YAC-1 as 
target. Infection with both  T. cruzi  populations (18 h 
post-infection, h.p.i.) raised the lytic capacity of splenic 
NK cells above sham-infected mice ( fig. 4 a). Mobilization 
of CD107a (LAMP-1) to the cell surface as a correlate of 
degranulation by activated circulating NK cells also in-
creased significantly 18 h.p.i. with both HV and LV pop-
ulations of  T. cruzi  (online suppl. fig. 2). NK cell-mediat-
ed elimination of iDCs contributes to the induction of 
immune responses via a reduction in the iDC pool. In 
view of the observed accumulation of DCs with poor mat-
uration status after infection with the HV  T. cruzi popula-
tions, we examined NK cell cytotoxicity of iDCs from in-
fected animals. Therefore, we performed an in vitro cyto-
toxicity assay using iDCs derived from bone marrow 
precursors as targets. NK cells isolated from the spleen of 
mice infected with the LV  T. cruzi strain increased sig-
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 Fig. 4. NK cell-mediated lysis of YAC-1 cells and iDCs upon  T. 
cruzi infection.  a Lysis of YAC-1 cells by splenic NK cells from  T. 
cruzi HV, LV or sham-infected (18 h.p.i.) and LPS (100 μg/mouse) 
inoculated C3H/HeN mice was evaluated. YAC-1 cells (5 × 10 4 ) 
were cultured with freshly purified splenic NK cells at a NK/YAC-1 
ratio of 5/1. Left panel shows CFSE-labeled YAC-1 cells and middle 
panel shows PI uptake by CFSE+ cells gated in R. Results from a 
representative experiment with 3–5 pooled mice per group. Right 
panel show results of 3 independent experiments with 3–5 pooled 
mice per group (means ± SEM). ANOVA (Bonferroni’s post hoc 
test).  *  p < 0.05 sham vs. LV and HV.  b iDCs (5 × 10 4 ) were cultured 
with freshly purified spleen NK cells from HV, LV and sham-in-
fected (18 h.p.i.) C3H/HeN mice. Left panel shows CFSE-labeled 
YAC-1 cells and middle panel shows PI uptake by CFSE+ cells gat-
ed in R. Results from a representative experiment with 3–5 pooled 
mice per group. Right panel shows results of 3 independent exper-
iments with 3–5 pooled mice per group (means ± SEM). ANOVA 






( fig. 4 b). In contrast, NK cells from mice infected with the 
HV strain failed to upregulate their capacity to lyse iDCs. 
Next, we tested the ability of NK cells from  T. cruzi- in-
fected mice to induce maturation/activation of iDCs. Co-
culture with NK cells from  T. cruzi -infected mice failed 
to modulate the expression of MHC class II or to stimu-
late their cytokine secretion of TNF-α or IL-10 (online 
suppl. fig. 3).
 IL-10 Participates in the NK Cell-Mediated Deletion 
of iDCs 
 Recently, it has been demonstrated that IL-10 affects 
NK cell function  [29–31] and NK/DC crosstalk  [32, 33] . 
As this regulatory cytokine is produced by different cell 
types upon infection with  T. cruzi  [34, 35] , we tested 
whether IL-10 mediates NK cell-mediated deletion of 
iDCs .  First, we cocultured NK cells from HV-infected 
mice with iDCs in the presence of an IL-10R blocking an-
tibody ( fig. 5 a). The ability of NK cells to lyse iDCs was 
increased when IL-10 consumption was prevented by IL-
10R blockade during NK-DC coculture. Next, NK cells 
from IL-10KO mice infected with the HV  T. cruzi  strain 
were cocultured with iDCs. The IL-10KO mice were of 
Balb/c background, a mouse strain susceptible to  T. cruzi 
which also displays a divergent outcome upon infection 
with HV and LV  T. cruzi populations  [36] . NK cells ob-
tained from IL-10KO infected mice displayed a signifi-
cantly higher capacity to lyse iDCs ( fig. 5 b). Regarding 
DC maturation/activation, the absence of IL-10 during 
infection did not further confer the capacity to mediate in 
vitro maturation of DCs to NK cells (data not shown).
 Discussion 
 Different studies show that NK cells mediate, at least 
in part, the clearance of iDCs  [1, 2, 5, 6] . This mechanism 
optimizes the conditions for T-cell priming and confers 
to NK cells a role in shaping the response at the interphase 
of innate and adaptive immunity  [7] . We have previously 
demonstrated that trypomastigotes and parasite-derived 
molecules from the HV strain downmodulate DC matu-
ration and the capacity to activate T cells  [17–19, 26] . 
Other authors have described a similar trend following 
infection with different HV  T. cruzi strains  [37, 38] . Here, 
the downregulation of splenic DC subset maturation is 
early noticeable (48 h.p.i.) and sustained during the acute 
phase of the infection with the HV strain but not with the 
LV strain. Moreover, the frequency, absolute number and 
MHC II expression of splenic DC subsets show that, dur-
ing acute infection with the HV  T. cruzi population, DCs 
with a poor maturation status accumulate in the spleen. 
The parasite burden in the spleen of mice infected with 
the HV strain increases notably from day 15 to 28 d.p.i. 


































 Fig. 5. IL-10 mediates NK cell cytotoxicity on iDCs. Mice were in-
fected with HV  T. cruzi .  a iDCs (5 × 10 4 per well) were cultured 
with freshly purified spleen NK cells (NK/DC ratio: 2/1) from HV 
( ■ ) and sham-infected ( □ ) C3H/HeN male mice (18 h.p.i.) in the 
presence of an IL-10R blocking antibody (Ab; 40 μg/ml, clone 
1B1.3A) or rat IgG isotype control (HPRN). Results are expressed 
as percent lysis from 2 independent experiments with 4–5 pooled 
mice per group (means ± SEM). ANOVA (Bonferroni’s post hoc 
test).  *  p< 0.05 vs. sham isotype.  b iDCs (5 × 10 4 /well) were cul-
tured with freshly purified spleen NK cells (NK/DC ratio: 2/1) 
from IL-10KO mice of Balb/c background or wild-type (WT) mice 
(18 h.p.i.). Results are expressed as percent lysis from 2 indepen-
dent experiments with 4–5 pooled mice per group (means ± SEM). 
ANOVA (Bonferroni’s post hoc test).  *  p< 0.05 vs. HV WT. 
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 Our results suggest that early in vivo  T. cruzi infection 
does not stimulate the NK cell-induced capacity to ma-
ture or activate iDCs. Furthermore, splenic NK cells from 
mice infected with the HV  T. cruzi strain but not with the 
LV strain are significantly impaired in their ability to 
eliminate autologous myeloid iDCs. This occurs even 
though NK cells from mice infected with both  T. cruzi 
populations display similar cytotoxic capacity against 
YAC-1 cells. The discrepant sensitivity of cell targets to 
NK cell cytotoxicity is not unexpected since they seem to 
require different receptor-ligand interactions which are 
not fully characterized in mice  [39] . In humans, NK-me-
diated killing of DCs appears to involve NKp30  [1] and 
the recognition on DCs of specific non-MHC ligands (i.e. 
costimulatory molecules)  [4, 5] . Due to infection with the 
HV  T. cruzi  strain, NK cells probably lose their capacity 
to delete iDCs, which results in iDC accumulation in the 
spleen. Defective NK cell lysis of autologous iDCs was 
also demonstrated in the context of HIV infection  [32, 40, 
41] . Elimination of iDCs by NK cells from HIV-1-infect-
ed viremic patients is markedly reduced compared to that 
of NK cells from either aviremic HIV-1-infected subjects 
or healthy donors  [41] . Aside from infectious diseases, 
NK cells from patients with acute myeloid leukemia dis-
play a defective ability to kill iDC  [42] . The alteration in 
NK/DC cooperation was proposed by different authors as 
a common mechanism elicited by tumors and pathogens 
to escape from immune surveillance  [7, 42] . Perhaps to 
avoid immune recognition,  the intracellular protozoan  T. 
gondii exploits direct contact of these cells  in vitro via its 
transfer from infected DCs to effector NK cells  [43] . 
 IL-10 is a pleiotropic cytokine whose immunosup-
pressive impact has been well documented. In the course 
of  T. cruzi infection, IL-10 is induced by various cell types, 
including diverse T-cell subsets and DCs  [17, 18, 26, 34, 
35] . We show here that blockade of IL-10R during NK/
DC coculture or the absence of IL-10 during in vivo  T. 
cruzi  infection restores the capacity of NK cells to mediate 
killing of iDC. The IL-10-induced downmodulation of 
NK cell-mediated DC killing could also occur in vivo as 
the production of this cytokine by spleen cells is increased 
shortly after infection with the HV  T. cruzi strain. The 
impact of this regulatory cytokine on NK-DC interac-
tions during viral infection has been verified. IL-10 sup-
presses NK-DC crosstalk leading to poor priming of 
mouse cytomegalovirus-specific CD4 T cells and to viral 
persistence  [33] . HIV induced IL-10 secretion makes DCs 
resistant to NK cell cytolysis  [32] . In the steady state, IL-
10 renders liver NK cells hyporesponsive, thus contribut-
ing to the tolerogenic environment of this organ  [30] .
 Our data also demonstrate for the first time that ear-
ly infection with the protozoan parasite  T. cruzi increas-
es significantly the proportion of circulating and splen-
ic NK cells that produce IL-10. IL-10 production by NK 
cells has also been reported upon acute murine infec-
tion with rapidly disseminating bacteria, e.g.  Listeria 
monocytogenes, Yersinia pestis and the parasitic proto-
zoa  Leishmania donovani  [44] and  Toxoplasma gondii 
 [45] . It was demonstrated that during acute systemic, 
but not local infections, NK cells coproduce IFN-γ and 
IL-10 resulting in immune regulation  [45] . Although we 
failed to detect the simultaneous production of both cy-
tokines, we hypothesize that  T. cruzi- induced IL-10 pro-
duction by NK cells probably could lead to weakened 
host resistance or provide a negative feedback to limit 
inflammation. In fact, a regulatory role for NK cells 
during  T. cruzi infection has been proposed by Cardillo 
et al.  [46] , who reported that NK1.1-positive cells are 
necessary at the beginning of infection to control sus-
ceptibility and T-cell hyperactivity of  T. cruzi- infected 
mice. 
 The major role of NK cells shortly after  T. cruzi in-
fection is to contribute to trypanocidal mechanisms 
mainly through the early production of macrophage-
activating cytokines as IFN-γ in response to infection 
 [11, 12] or by directly killing extracellular parasites  [14] . 
Accordingly, in our model, during the first hours of in 
vivo infection with HV and LV  T. cruzi populations, in-
creases in the frequency, CD69 expression and cytotox-
ic capacity of circulating NK cells were noted. We show 
here that  T. cruzi -activated NK cells from the splenic 
compartment might also have an accessory role in regu-
lating the strength of adaptive immune responses in-
duced by DCs. Acute infection with the HV strain sig-
nificantly impairs T-cell responses to mitogens, DC 
maturation/activation and, as we previously reported, 
stimulation of  T. cruzi- specific CD4 T-cell responses 
probably delaying the induction of adaptive immune re-
sponses  [19] . This parasite strain could also downmod-
ulate in vivo the ability of NK cells to adjust the matu-
ration level of the DC pool. Through this mechanism, 
probably mediated by IL-10, the parasite might engage 
NK cells and DCs in a regulatory circuit which leads to 
parasite persistence but prevents host death due to ex-
cessive inflammation. Understanding the interactions 
between DCs and NK cells that regulate anti-parasite 
responses at the frontier of innate and adaptive immu-
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